Hong Kong-listed China Traditional Chinese Medicine Co. Limited has agreed to acquire 81.48% of Jiangsu province-based Jiangyin Tianjiang Pharmaceutical Co., Ltd., which is backed by China International Capital Corporation (CICC), according to a company announcement. The cash transaction, which would allow two CICC funds to make an exit from its investment in Tianjiang Pharmaceutical, is […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network